Targeting MET Amplification as a New Oncogenic Driver

Author： Kawakami Hisato   Okamoto Isamu   Okamoto Wataru   Tanizaki Junko   Nakagawa Kazuhiko   Nishio Kazuto  

Publisher： MDPI

E-ISSN： 2072-6694|6|3|1540-1552

ISSN： 2072-6694

Source： Cancers, Vol.6, Iss.3, 2014-07, pp. : 1540-1552

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes

By Sala Valentina   Gallo Simona   Gatti Stefano   Vigna Elisa   Ponzetto Antonio   Crepaldi Tiziana  

Biomedicines, Vol. 3, Iss. 1, 2015-02 ,pp. : 124-137

MDPI

Access to resources Recommend Favorite

Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression

By Rad Ellie   Murray James T.   Tee Andrew R.  

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice

By Stabile Laura P.   Rothstein Mary E.   Keohavong Phouthone   Lenzner Diana   Land Stephanie R.   Gaither-Davis Autumn L.   Kim K. Jin   Kaminski Naftali   Siegfried Jill M.  

Cancers, Vol. 2, Iss. 4, 2010-12 ,pp. : 2153-2170

MDPI

Access to resources Recommend Favorite

Editorial of Special Issue “New Aspects of the Hepatocyte Growth Factor/c-Met System”

By Ricci Giulia  

Biomedicines, Vol. 3, Iss. 2, 2015-06 ,pp. : 201-202

MDPI

Access to resources Recommend Favorite

New Trends in Cancer Therapy: Targeting Ion Channels and Transporters

By Arcangeli Annarosa   Becchetti Andrea  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1202-1224

MDPI

Access to resources Recommend Favorite